EP
MEDP icon

Essential Partners’s Medpace MEDP Stock Holding History

Essential Partners’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$171K Sell
323
-1,442
-82% -$665K 0.08% 277
2026
Q1 		$848K Sell
1,765
-776
-31% -$397K 0.29% 83
2025
Q4 		$1.43M Buy
2,541
+478
+23% +$271K 0.44% 52
2025
Q3 		$1.06M Buy
2,063
+697
+51% +$304K 0.35% 73
2025
Q2 		$429K Buy
+1,366
New +$410K 0.17% 175

Other funds holding MEDP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Essential Partners's MEDP Position: Q2 2026 in Review

Essential Partners reduced its Medpace (MEDP) stake by 82% in Q2 2026, selling an estimated $665K and leaving 323 shares worth $171K. The position accounts for 0.08% of the portfolio, ranked #277.

Essential Partners first reported a position in MEDP in Q2 2025 and has held it in 5 quarters since. The position peaked at $1.43M in Q4 2025. 695 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • Essential Partners held 323 shares of Medpace worth $171K as of Q2 2026.
  • Essential Partners sold 1,442 Medpace shares in Q2 2026, an estimated $665K.
  • Medpace made up 0.08% of Essential Partners's portfolio in Q2 2026, its #277 holding.
  • Essential Partners first reported a position in Medpace in Q2 2025 and has held it in 5 quarters since.
  • Essential Partners's Medpace position peaked at $1.43M in Q4 2025.
  • 695 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on Essential Partners's 13F filing for Q2 2026, filed 10 Aug 2026.